Document is current
Any future updates will be listed below
-
Authors
Satake, Tomoyuki
Morizane, Chigusa
Machida, Nozomu
Honma, Yoshitaka
Okusaka, Takuji
Boku, Narikazu
Kato, Ken
Ogawa, Gakuto
Sano, Yusuke
Imaoka, Hiroshi
Kobayashi, Satoshi
Terashima, Takeshi
Ikeda, Masafumi
Okano, Naohiro
Yamaguchi, Kensei
Sato, Takuji
Mizuno, Nobumasa
Kitagawa, Yuko
Terashima, Masanori
Ueno, Makoto
- License Information
-
More Information
Article History
Received: 20 April 2025
Accepted: 10 April 2026
First Online: 16 April 2026
Declarations
:
: TS received research funding from Nihon Servier, and received speaker honoraria from AstraZeneca and Chugai pharma.YH received consultation free from Janssen and Rakuten medical Japan, and received research funding from Taiho pharmaceutical, Chugai pharma, MSD, GlaxoSmithKline, Janssen, Adlai Nortye Biopharma, Maruho, Merck Biopharma, Genmab, Astellas pharma, Rakuten Medical Japan, and AstraZeneca. Also received honoraria from Novartis, Chugai pharma, MSD, Ono pharmaceutical, BMS, Merck Biopharma, Eisai, Eli Lilly, Nutri, Teijin pharma, Bayer, and Taiho pharmaceutical. YS received research funding from AstraZeneca, Ono Pharmaceutical and Chugai Pharmaceutical.HI received research funding from Novartis Pharma, and received speaker honoraria from Novartis Pharma.TT received speaker honoraria from AstraZeneca, K.K, MSD K.K, Nihon Servier Co., Ltd., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., and Novartis Pharma.MI received research funding from Syneos Health, and received speaker honoraria from Novartis and Teijin Pharma.NO received honoraria from Taiho Pharmaceutical, Eisai, Bayer Yakuhin, Chugai Pharma, Ono Pharmaceutical, Daiichi Sankyo, AstraZeneca, MSD, Incyte, and Nihon Servier.NM has received Grants or contracts from any entity from to his institution from Novartis, MSD, Incyte, Ono Pharmaceutical, Seagen, Boehringer Ingelheim, Pfizer, AstraZeneca, SERVIER; and has received payment or honoraria (to him) for lectures, presentations, speakers bureaus, manuscript writing or educational events from Yakult Honsha, AstraZeneca, Novartis, FUJIFILM Toyama Chemical, Taiho Pharmaceutical, Miyarisan pharmaceutical; and has participated on an Advisory Board (payments were made to him) for MSD, Boehringer Ingelheim.MT received honoraria from Taiho Pharmaceutical Co., Ltd.; Chugai Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Bristol Myers Squib Japan K.K.; Yakult Honsha Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Eli Lilly Japan K.K.; Pfizer Japan Inc.; Daiichi Sankyo Ltd.; Johnson and Johnson K.K.; Medtronic Japan Co., Ltd.; Intuitive Japan Inc.; and Olympus Co., Ltd.MU received honoraria from Taiho Pharmaceutical Co., Ltd., AstraZeneca, K.K, Yakult Honsha Co., Ltd., MSD K.K, Nihon Servier Co., Ltd., Ono Pharmaceutical Co., Ltd., Incyte Biosciences Japan GK, Chugai Pharmaceutical Co., Ltd., Boehringer Ingelheim GmbH, J-pharma Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Novartis Pharma K.K, and received research funding from Taiho Pharmaceutical Co., Ltd., AstraZeneca, K.K, MSD K.K, Nihon Servier Co., Ltd., Ono Pharmaceutical Co., Ltd., Incyte Biosciences Japan GK, Chugai Pharmaceutical Co., Ltd., Boehringer Ingelheim GmbH, Eisai Co., Ltd., Novartis Pharma K.K, Astellas Pharma Inc., J-pharma Co., Ltd., DFP (Delta Fly Pharma), Inc., Amgen Inc., and Chiome Bioscience Inc.The other authors have no disclosures to report.
